Skip to main content
Premium Trial:

Request an Annual Quote

Complete Genomics Inks $20M Loan Agreement

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Complete Genomics has entered into an agreement with Oxford Finance for a $20 million loan, the Mountain View, Calif.-based firm disclosed in its quarterly earnings report filed yesterday with the US Securities and Exchange Commission.

Complete Genomics entered into the loan and security agreement on March 25, it said in the document, adding that a portion of the loan was used to repay the remaining balance of $7.4 million on an existing loan from Comerica. After repayment, the Comerica loan agreement was terminated, it said.

The company said that the remaining funds from the Oxford loan will be used to fund Complete Genomics' working capital requirements.

In connection with the agreement, the genomic testing firm issued warrants to Oxford to purchase an aggregate of 160,128 share of its common stock at an exercise price of $7.495 per share. The warrants will expire on the seventh anniversary of the issuance date.

Complete Genomics reported earlier this week that it posted first-quarter revenues of $6.8 million and had filed for a proposed offering to sell 4.5 million shares of its common stock.

The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.